Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) for Opioid Use Disorder

NCT04850664 is registered in ClinicalTrials.gov with Evon Medics LLC as lead sponsor.

NCT NCT04850664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04850664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) for Opioid Use Disorder
Lead sponsor
Evon Medics LLC
Phase
Phase 2
Overall status
Unknown status
Start date
March 26, 2021
Completion date
December 31, 2022
Enrollment
190 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

craving, negative affectivity, opioid use disorder, moderate, opioid use disorder, severe, withdrawal symptoms